BLASI, FRANCESCO BRUNO ARTURO
BLASI, FRANCESCO BRUNO ARTURO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Bronchiectasis and sinonasal diseases: a narrative review
2025 E. Simonetta, A. De Angelis, M.S. Silani, V. Polelli, M. Nigro, A. Stainer, F. Amati, A. Gramegna, F. Pirola, G. Mercante, F. Blasi, L. Malvezzi, S. Aliberti
Intermediate Care Unit performance being properly assessed?
2025 S. Accordino, C. Canetta, F.B. Sozzi, F. Blasi
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
2025 J. Pollock, E. Polverino, R. Dhar, K. Dimakou, L. Traversi, A. Bossios, C. Haworth, M.R. Loebinger, A. De Soyza, M. Vendrell, P.R. Burgel, P. Mertsch, M.J. Mcdonnell, S. Skgrat, L. Maiz-Carro, O. Sibila, M. Van Der Eerden, P. Kauppi, A.T. Hill, R. Wilson, B. Milenkovic, R. Menéndez, M. Murris, M.L. Crichton, S. Borecki, D. Obradovic, M. Irfan, V. Eshenkulova, A. Nowinski, A. Amorim, A. Torres, N. Lorent, T. Welte, F. Blasi, E. Van Braeckel, J. Altenburg, M. Shteinberg, W. Boersma, J.S. Elborn, S. Aliberti, F.C. Ringshausen, P. Goeminne, J.D. Chalmers
Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection
2025 C. Lanfranchi, G. Alicandro, L. Cariani, B.S. Orena, A. Gramegna, C. Rizza, F. Blasi, V. Daccò
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2025 J.D. Chalmers, P. Burgel, C.L. Daley, A. De Soyza, C.S. Haworth, D. Mauger, M.R. Loebinger, P.J. Mcshane, F.C. Ringshausen, F. Blasi, M. Shteinberg, K. Mange, A. Teper, C. Fernandez, M. Zambrano, C. Fan, X. Zhang, M.L. Metersky
Awareness of respiratory syncytial virus and other respiratory disease vaccines among healthcare professionals and their patients in Italy: Insights from a literature review and a web-based survey
2025 C. Micheletto, G. Lorenzini, S. De Grazia, F. Di Marco, R. Di Matteo, P. Faverio, A. Gramegna, M. Vicentini, F. Blasi
Impact of elexacaftor/tezacaftor/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: an Italian multicenter analysis
2025 A. Gramegna, G. Cimino, M. Cipolli, G. Gandini, M.A. Calderazzo, A. Profiti, F. Piedepalumbo, F. Blasi
Diagnostic and prognostic trajectories of interstitial lung diseases after the multidisciplinary discussion
2025 F. Amati, D.L. Kellogg, M.I. Restrepo, F. Blasi, S. Aliberti, A.M. Nambiar
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant
2025 C. Pastorino, L. Menta, E. Pesce, M. Lena, V. Tomati, V. Capurro, M. Di Duca, V. Terlizzi, A. Gramegna, F. Blasi, C. Castellani, S. Cappato, F. Zara, N. Pedemonte, R. Bocciardi
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
2025 L. Pini, M. Caminati, M. Maule, D. Bagnasco, B. Beghè, B. Bondi, F. Braido, P. Cameli, C. Caruso, C. Crimi, Y. El Masri, J. Giordani, G. Guarnieri, M. Latorre, A. Mastrototaro, F. Menzella, C. Micheletto, A. Pini, S. Piras, A. Spanevello, A. Vianello, D. Visca, M. Zappa, M. Zurlo, P. Paggiaro, F. Blasi, G.W. Canonica, G. Senna, R. Benoni
A destruent case of recurrent primary naso-pharyngeal tuberculosis in a migrant
2025 A.S. Sarassi, N. Riccardi, G. Fumagalli, A. Pelosi, A.C. Repossi, M. Ferrarese, M. Mantero, F.B.A. Blasi, L.R. Codecasa
Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI)
2025 G.W. Canonica, F. Blasi, P. Paggiaro, E. Heffler, F. Braido, L. Brussino, G. Scioscia, C. Cardini, C. Oriecuia, I. Sala, V. Bagnardi, C. Calabrese, G. Camiciottoli, G.E. Carpagnano, S. Centanni, A.G. Corsico, M.T. Costantino, C. Crimi, A. D'Adda, S. D'Alò, M. D'Amato, C. D'Andria, S. Del Giacco, F. Di Marco, N.C. Facciolongo, A. Farsi, M. Latorre, M. Milanese, E. Nettis, E. Nucera, G. Passalacqua, G. Pelaia, L. Pini, L. Ricciardi, F.L. Massimo Ricciardolo, L. Richeldi, E. Ridolo, P. Santus, N. Scichilone, G. Senna, G. Spadaro, A. Spanevello, P. Tarsia
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study
2025 O. Sibila, J. Stobo, L. Perea, Y. Gao, J. Xu, H. Lind, K. Viligorska, A. Spinou, E. Polverino, F.C. Ringshausen, M. Vendrell, P. Burgel, C.S. Haworth, M.R. Loebinger, N. Lorent, R. Dhar, H. Choi, S.H. Chotirmall, A. De Soyza, J.R. Hurst, J.S. Brown, M. Van Der Eerden, P. Kauppi, E.D. Johnson, R. Mendez, K. Dimakou, A. Bossios, A. Torres, F. Blasi, M. Shteinberg, S.J. Elborn, P.C. Goeminne, S. Aliberti, L. Jayaram, N. Karalus, S.L. Taylor, M.L. Martin, L.D. Burr, C. Wong, L. Terpstra, J. Altenburg, W. Boersma, J.D. Chalmers
Role of body anthropometry in severe asthmatic patients: Evidences from the Severe Asthma Network in Italy (SANI) registry
2025 E. Ridolo, M. Ottoni, F. Nicoletta, F. Locatelli, L. Martinelli, M. Maule, N.A. Cheema, F. Blasi, P. Paggiaro, E. Heffler, L. Brussino, G.W. Canonica, G. Senna, M. Caminati, D. Bagnasco, C. Calabrese, G. Camiciottoli, G.E. Carpagnano, C. Caruso, A. Guido Corsico, M.T. Costantino, C. Crimi, A. D'Adda, S. D'Alò, M. D'Amato, C. D'Andria, S. Del Giacco, F. Di Marco, N.C. Facciolongo, A. Farsi, M. Latorre, M. Milanese, M. Mondoni, E. Nettis, G. Pelaia, L. Pini, L. Ricciardi, F.L. Massimo Ricciardolo, L. Richeldi, P. Santus, N. Scichilone, G. Scioscia, G. Spadaro, A. Spanevello, P. Tarsia, M.R. Yacoub
Profile of mild/moderate asthma patients: Baseline data from the MANI cohort
2025 G.E. Carpagnano, M. Bonini, M. Latorre, E. Nucera, I. Prediletto, F. Puggioni, G. Scioscia, P. Santus, G. Sotgiu, F. Blasi, G.W. Canonica, P. Paggiaro, A. Aruanno, I. Baiardini, D. Bagnasco, B. Bondi, G. Candeliere, F. Cefaloni, G. Fontanili, L. Melissari, M. Mincarini, G. Paoletti, D. Radovanovic, V. Pinelli, P. Tondo, V.N. Quaranta, R. Vallara, F. Braido
Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI
2025 C. Micheletto, S. Aliberti, M. Andreoni, F. Blasi, F. Di Marco, R. Di Matteo, G. Gabutti, S. Harari, I. Gentile, R. Parrella, R. Siliquini, L. Sticchi, N. Null, N. Null, N. Null, N. Null, N. Null
Clinical Efficacy of Serum Antiglycopeptidolipid Core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis
2025 H. Choi, C. Hughes, Z. Eke, M. Shuttleworth, M. Shteinberg, E. Polverino, P.C. Goeminne, T. Welte, F. Blasi, A. Shoemark, M.B. Long, S. Aliberti, C.S. Haworth, F.C. Ringshausen, M.R. Loebinger, N. Lorent, J.D. Chalmers
Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial
2025 E.D. Johnson, M.B. Long, L. Perea, V.H. Shih, C. Fernandez, A. Teper, D. Cipolla, E. Mcintosh, R. Galloway, Z. Eke, M. Shuttleworth, R. Hull, A. Spinou, A. De Soyza, F.C. Ringshausen, P. Goeminne, N. Lorent, C. Haworth, M.R. Loebinger, F. Blasi, M. Shteinberg, S. Aliberti, E. Polverino, O. Sibila, A. Shoemark, K. Mange, J.T.J. Huang, J. Stobo, J.D. Chalmers
Lung disease in never-smokers with severe α1 -antitrypsin deficiency: the EARCO Registry
2025 C. Premuda, C. Aljama, G. Granados, I. Ferrarotti, A.G. Corsico, A.M. Turner, M. Torres-Duran, H. Tanash, C. Rodríguez-García, J.S. Jensen, M. Mantero, F. Blasi, M. Miravitlles, M. Barrecheguren, C. Esquinas
Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in children and adolescents with cystic fibrosis and normal spirometry
2025 G. Alicandro, V. Terlizzi, L. Zazzeron, D. Dolce, L. Cariani, A. Fiandaca, S. Campana, A. Terminiello, D. Innocenti, F. Blasi, V. Daccò